Dr. Mark Einstein, MD, MS

Claim this profile

University Hospital, Rutgers New Jersey Medical School

Studies Squamous Intraepithelial Lesion
Studies Atypical squamous cells
4 reported clinical trials
11 drugs studied

Area of expertise

1Squamous Intraepithelial Lesion
Mark Einstein, MD, MS has run 2 trials for Squamous Intraepithelial Lesion. Some of their research focus areas include:
HPV16
CIN2
HIV-1 positive
2Atypical Squamous Cells
Mark Einstein, MD, MS has run 1 trial for Atypical squamous cells. Some of their research focus areas include:
HPV16
CIN2

Affiliated Hospitals

Image of trial facility.
University Hospital, Rutgers New Jersey Medical School
Image of trial facility.
Rutgers New Jersey Medical School

Clinical Trials Mark Einstein, MD, MS is currently running

More about Mark Einstein, MD, MS

Clinical Trial Related10 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Mark Einstein, MD, MS has experience with
  • PNGVL4a-Sig/E7(detox)/HSP70 DNA
  • TA-CIN
  • Placebo
  • VB-111
  • Paclitaxel
  • Fluorouracil

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mark Einstein, MD, MS specialize in?
Mark Einstein, MD, MS focuses on Squamous Intraepithelial Lesion and Atypical squamous cells. In particular, much of their work with Squamous Intraepithelial Lesion has involved HPV16 patients, or patients who are CIN2.
Is Mark Einstein, MD, MS currently recruiting for clinical trials?
Yes, Mark Einstein, MD, MS is currently recruiting for 1 clinical trial in Newark New Jersey. If you're interested in participating, you should apply.
Are there any treatments that Mark Einstein, MD, MS has studied deeply?
Yes, Mark Einstein, MD, MS has studied treatments such as pNGVL4a-Sig/E7(detox)/HSP70 DNA, TA-CIN, Placebo.
What is the best way to schedule an appointment with Mark Einstein, MD, MS?
Apply for one of the trials that Mark Einstein, MD, MS is conducting.
What is the office address of Mark Einstein, MD, MS?
The office of Mark Einstein, MD, MS is located at: University Hospital, Rutgers New Jersey Medical School, Newark, New Jersey 07103 United States. This is the address for their practice at the University Hospital, Rutgers New Jersey Medical School.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.